AOD 9604 Peptide: The Complete Guide to Targeted Fat Loss, Dosage Protocols, and the Clinical Science Behind the Most Specific Lipolytic Peptide

The Only Complete Science-Based Reference on AOD 9604 Peptide Therapy for Fat Loss, Body Composition, and Metabolic OptimizationAOD 9604 is the most mechanistically specific lipolytic peptide ever tested in controlled human clinical trials. Derived from the C-terminal fragment of human growth hormone (hGH fragment 177-191), it was engineered to trigger targeted fat loss through beta-3 adrenergic receptor signaling without raising IGF-1, disrupting insulin, or producing the side effects that made full HGH therapy impractical for metabolic use. Six randomized, double-blind, placebo-controlled clinical trials. Nearly nine hundred human subjects. A safety profile statistically indistinguishable from placebo. This is not a wellness trend. This is a documented compound with a real scientific record, and this book covers all of it.Inside you will find the complete preclinical research record from Zucker rat and obese mouse model studies, a full review of the ADIP human clinical trial series, Phase I through III outcomes, and the FDA GRAS oral designation. The book covers subcutaneous injection dosage protocols from 250 to 500 mcg, fasted morning timing rationale, 8 to 12 week cycle structures, and beginner through advanced dosing tables. You will find stacking protocols combining AOD 9604 with CJC-1295 and ipamorelin, emerging combination approaches with semaglutide and tirzepatide, intermittent fasting synergies, and exercise programming for maximum lipolysis. Beyond fat loss, the book covers targeted visceral fat reduction, lean muscle mass preservation, cartilage repair and osteoarthritis data, insulin resistance management, and skin regeneration applications.The safety profile chapter presents adverse event frequencies from clinical trial data, contraindications, drug interactions, and guidance on pregnancy and cancer history. The sourcing chapter explains how to identify pharmaceutical-grade peptides, how to read a Certificate of Analysis, how to reconstitute with bacteriostatic water, and how to store lyophilized and reconstituted peptides correctly. The final chapters look ahead at next-generation oral delivery systems, NAFLD and metabolic disease research directions, and the future of peptide medicine over the next five years.Written for practitioners in functional medicine and peptide therapy, for informed patients, and for anyone serious about body composition who wants the actual science. Scientific, direct, and fully evidence-based. Read more